Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily C. Atkinson
Novel SPECC1L-MET Fusion Detected in Circulating Tumor DNA in a Patient With Lung Adenocarcinoma Following Treatment With Erlotinib and Osimertinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Growth and Nutrition in Children With Trichothiodystrophy
Journal of Pediatric Gastroenterology and Nutrition
Child Health
Pediatrics
Perinatology
Gastroenterology
Related publications
P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Letter to Editor Recovery From Paraplegia With Administration of Erlotinib in a Patient With Lung Adenocarcinoma
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-Small Cell Lung Cancer With the EGFR T790M Mutation, Detected From Circulating Tumor DNA: LiquidLung-O-Cohort 2
Cancer Research and Treatment
Cancer Research
Oncology
Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient With MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report
Oncology Letters
Cancer Research
Oncology
Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma With G719S, S768I, and T790M Mutations
Internal Medicine
Internal Medicine
Medicine
P1.01-77 Osimertinib in the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutation From Circulating Tumor DNA
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Erlotinib in Symptomatic Brain Metastases From a Lung Adenocarcinoma With a Sensitizing EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary